Favero et al., 2019 - Google Patents
Inflammatory molecules produced by meniscus and synovium in early and end‐stage osteoarthritis: a coculture studyFavero et al., 2019
View PDF- Document ID
- 8010033473637496256
- Author
- Favero M
- Belluzzi E
- Trisolino G
- Goldring M
- Goldring S
- Cigolotti A
- Pozzuoli A
- Ruggieri P
- Ramonda R
- Grigolo B
- Punzi L
- Olivotto E
- Publication year
- Publication venue
- Journal of cellular physiology
External Links
Snippet
The aim of this study was to identify the molecules and pathways involved in the cross‐talk between meniscus and synovium that may play a critical role in osteoarthritis (OA) pathophysiology. Samples of synovium and meniscus were collected from patients with …
- 230000005499 meniscus 0 title abstract description 112
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Favero et al. | Inflammatory molecules produced by meniscus and synovium in early and end‐stage osteoarthritis: a coculture study | |
Chou et al. | Synovial cell cross-talk with cartilage plays a major role in the pathogenesis of osteoarthritis | |
Diekman et al. | Expression of p16 INK 4a is a biomarker of chondrocyte aging but does not cause osteoarthritis | |
Hsueh et al. | Synergistic roles of macrophages and neutrophils in osteoarthritis progression | |
Li et al. | XIST/miR‐376c‐5p/OPN axis modulates the influence of proinflammatory M1 macrophages on osteoarthritis chondrocyte apoptosis | |
Eymard et al. | Induction of an inflammatory and prodegradative phenotype in autologous fibroblast‐like synoviocytes by the infrapatellar fat pad from patients with knee osteoarthritis | |
Liang et al. | MiRNA-140 is a negative feedback regulator of MMP-13 in IL-1β-stimulated human articular chondrocyte C28/I2 cells | |
Platas et al. | Conditioned media from adipose‐tissue‐derived mesenchymal stem cells downregulate degradative mediators induced by interleukin‐1β in osteoarthritic chondrocytes | |
Assirelli et al. | Human osteoarthritic cartilage shows reduced in vivo expression of IL-4, a chondroprotective cytokine that differentially modulates IL-1β-stimulated production of chemokines and matrix-degrading enzymes in vitro | |
Nakamura et al. | Identification of microRNA-181a-5p and microRNA-4454 as mediators of facet cartilage degeneration | |
Wang et al. | LncRNA H19 targets miR‐22 to modulate H2O2‐induced deregulation in nucleus pulposus cell senescence, proliferation, and ECM synthesis through Wnt signaling | |
Xu et al. | The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis | |
Liu | The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis | |
Tchetina et al. | Differences in Mammalian target of rapamycin gene expression in the peripheral blood and articular cartilages of osteoarthritic patients and disease activity | |
McCarthy et al. | Basic calcium phosphate crystals activate human osteoarthritic synovial fibroblasts and induce matrix metalloproteinase-13 (collagenase-3) in adult porcine articular chondrocytes | |
Bougault et al. | Stress‐induced cartilage degradation does not depend on the NLRP3 inflammasome in human osteoarthritis and mouse models | |
Johnson et al. | TNF-α promotes nuclear enrichment of the transcription factor TonEBP/NFAT5 to selectively control inflammatory but not osmoregulatory responses in nucleus pulposus cells | |
Long et al. | Rac1 is required for matrix metalloproteinase 13 production by chondrocytes in response to fibronectin fragments | |
Zhou et al. | Influence of osteoarthritis grade on molecular signature of human cartilage | |
Li et al. | The protective effect of sinapic acid in osteoarthritis: In vitro and in vivo studies | |
Wang et al. | Reduced miR-9 and miR-181a expression down-regulates Bim concentration and promote osteoclasts survival | |
Wilson et al. | Novel elements of the chondrocyte stress response identified using an in vitro model of mouse cartilage degradation | |
Fioravanti et al. | Exploring the Involvement of NLRP3 and IL‐1β in Osteoarthritis of the Hand: Results from a Pilot Study | |
Han et al. | Periostin interaction with discoidin domain receptor-1 (DDR1) promotes cartilage degeneration | |
Bao et al. | circFAM160A2 promotes mitochondrial stabilization and apoptosis reduction in osteoarthritis chondrocytes by targeting miR‐505‐3p and SIRT3 |